126811-30-1 Usage
General Description
4-Bromo-7-chloro-1H-indole, also known as 7-Chloro-4-bromoindole, is a chemical compound with the molecular formula C8H5BrClN. It is a halogenated indole derivative, belonging to the class of organic compounds known as indoles. 4-BROMO-7-CHLORO-1H-INDOLE is a yellow solid at room temperature and is mainly used as a building block in the synthesis of pharmaceuticals and agrochemicals. It has potential applications in the pharmaceutical industry, particularly in the development of new medications. The compound's structure and properties make it a valuable tool in organic chemistry for the development of novel molecules with potential biological activity.
Check Digit Verification of cas no
The CAS Registry Mumber 126811-30-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,8,1 and 1 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 126811-30:
(8*1)+(7*2)+(6*6)+(5*8)+(4*1)+(3*1)+(2*3)+(1*0)=111
111 % 10 = 1
So 126811-30-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrClN/c9-6-1-2-7(10)8-5(6)3-4-11-8/h1-4,11H
126811-30-1Relevant articles and documents
ORGANIC COMPOUNDS AND ORGANIC ELECTRO LUMINESCENCE DEVICE COMPRISING THE SAME
-
Paragraph 0392-0394, (2016/10/08)
The present invention relates to a novel organic compound which can be used as a material for an organic electroluminescent element, and an organic electroluminescent element comprising the compound.
AURORA AND FLT3 KINASES MODULATORS
-
Page/Page column 40, (2013/08/28)
The invention provides a compound having the formula (1) useful as modulator of the activity of Aurora kinases and FLT3 kinases: and salts thereof; wherein: R1 is hydrogen or C1-2 alkyl; and R2, R3 and R4 are the same or different and each is selected from hydrogen, C1-2 alkyl, fluorine, chlorine, C1-2 alkoxy and trifluoromethyl, provided that no more than two of R2, R3 and R4 are other than hydrogen. Also provided are pharmaceutical compositions containing the compounds and their use in medicine, and in particular in the treatment of cancer
